| Treatment of newly diagnosed severe aplastic anemia in children: Evidence-based recommendations |
|
Pediatric Blood & Cancer |
Aplastic Anemia |
| A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the Nort |
|
Pediatric Blood & Cancer |
Aplastic Anemia, Pediatric |
| Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North American Pediatric Aplastic Anemia Consortium |
|
Pediatric Blood & Cancer |
Aplastic Anemia, Myelodysplastic Syndromes (MDS), Pediatric |
| Eltrombopag in children with severe aplastic anemia |
|
Pediatric Blood & Cancer |
Aplastic Anemia, Pediatric |
| Myelodysplastic Syndromes Treatment (PDQ®): Patient Version |
|
PDQ Cancer Information Summaries |
Myelodysplastic Syndromes (MDS) |
| Myelodysplastic Syndromes Treatment (PDQ®): Health Professional Version |
|
PDQ Cancer Information Summaries |
Myelodysplastic Syndromes (MDS) |
| Heterogeneity in Health-Related Quality of Life of Patients with Aplastic Anemia: A Latent Profile Analysis |
|
Patient Preference and Adherence |
Aplastic Anemia |
| Experience of life quality from patients with aplastic anemia: a descriptive qualitative study |
|
Orphanet Journal of Rare Diseases |
Aplastic Anemia |
| Real-World Study of the Burden of Myelodysplastic Syndromes in Patients and Their Caregivers in Europe and the United States |
|
Oncology and Therapy |
Myelodysplastic Syndromes (MDS) |
| Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes |
|
Oncologist |
Myelodysplastic Syndromes (MDS) |
